Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.. Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Astellas Pharma (South Korea), South Korea, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
72%
Total
Publications
57
Total Open
Publications
41
Total
Citations
511
Open Access
Percentage
72%
Total
Publications
57
Total Open
Publications
41
Total
Citations
511
Breakdown
Publisher Open
34%
Both
34%
Other Platform Open
4%
Closed
28%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 74%
28
Hybrid 16%
6
No Guarantees 10%
4
Other Platform Open
Domain 52%
11
Institution 43%
9
Other Internet 14%
3
Preprint 0%
0
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | Domain | 11 |
Yonsei University Medical Library - YUHSpace | Institution | 4 |
DOI | Other Internet | 2 |
AECID Library - Americanae | Institution | 2 |
Unknown Repository | Other Internet | 1 |
Universitat Autònoma de Barcelona - Dipòsit Digital de Documents de la UAB | Institution | 1 |
Universidad de Alicante - Repositorio Institucional de la Universidad de Alicante | Institution | 1 |
Library Stack - Library Stack | Institution | 1 |
Europe PMC | Domain | 1 |
CERN European Organization for Nuclear Research - Zenodo | Institution | 1 |